Cardiovascular Devices Market Size, Share and Industry Analysis, By Device Type (Diagnostic and Monitoring Devices, and Therapeutic and Surgical Devices), By Application (Coronary Artery Disease (CAD), Cardiac Arrhythmia, Heart Failure, and Others), By End User (Hospitals, Specialty Clinics, and Others), and Regional Forecast, 2019-2026 (Includes COVID-19 Business Impact)

                                          
We have updated Cardiovascular Devices Market with respect to COVID-19 Business Impact.
Inquire before buying


This report focuses on the Cardiovascular Devices market and value at the global level, regional level, and company level. From a global perspective, this report represents the overall Cardiovascular Devices market size by analyzing historical data and future prospects. Regionally, this report focuses on several key regions: North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America.


Global Cardiovascular Devices Market: Segment Analysis


The research report includes specific segments by region (country), by Company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2029. An in-depth analysis of the segments assists in identifying the different factors that will aid market growth.


Global Cardiovascular Devices Market: Regional Analysis


The research report includes a detailed study of regions of North America, Europe, Japan, China, Southeast Asia, India, Latin America, and South America. The report has been curated after observing and studying various factors that determine regional growth such as the economic, environmental, social, technological, and political status of the particular region. Researchers have studied the data of revenue, sales, and manufacturers of each mentioned region. This section analyses region-wise revenue and volume for the forecast period of 2019 to 2029.


Global Cardiovascular Devices Market: Competitive Landscape


This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2019 to 2029.
List of Companies Profiled

Medtronic Focuses on Introducing New Cardiovascular Devices to Obtain a Strategic Position in Global Market
Medtronic, Abbott, and Boston Scientific Corporation accounted for the maximum share in 2018, owing to the rising sales of cardiovascular devices globally. Medtronic dominates the global market due to its strong product sales owing to the companys strong product portfolio comprising of advanced stents, catheters, heart valves, and other cardiopulmonary products. For instance, in February 2018, Medtronic announced the launch of the first 2.0-mm drug-eluting stent in the United States, enabling the treatment of coronary artery disease in patients who were previously considered to be untreatable or hard to treat. Such launches are expected to increase the market revenue in the forthcoming years.

LIST OF KEY COMPANIES PROFILED IN THE REPORT:

  
Medtronic
  
Boston Scientific Corporation
  
Abbott
  
Edwards Lifesciences Corporation
  
Johnson & Johnson Services, Inc.
  
GENERAL ELECTRIC COMPANY (GE Healthcare)
  
B. Braun Melsungen AG
  
LivaNova PLC
  
Siemens Healthcare GmbH
  
Cordis (Cardinal Health)
  
Terumo Cardiovascular Systems Corporation
  
Others

KEY INDUSTRY DEVELOPMENTS:

October 2019 -BIOTRONIK announced the launch of the PK Papyrus Covered Coronary Stent in the United States, for usage in the emergency treatment of acute coronary perforations.

May 2019 -Medtronic announced the launch of the Telescope Guide Extension Catheter, a newly designed catheter for the additional backup support and the access to distal lesions, which will enable the support of the complex coronary cases where the distal lesions were not accessible.

October 2017 -Abbott announced the introduction of the next generation of the most widely used heart stent for people suffering from coronary artery disease in Europe called the XIENCE Sierra, which is the newest generation of drug-eluting XIENCE stent.

REPORT COVERAGE
The report offers qualitative and quantitative insights on cardiovascular devices and the detailed analysis of market size & growth rate for all possible segments in the market. Along with this, the report provides an elaborative analysis of market dynamics, emerging trends, and competitive landscape. Key insights offered in the report are the prevalence of key cardiovascular diseases, by key countries - 2018, technological advancements in these devices, new product launches, analysis of key cardiovascular devices deals, key industry developments, pipeline analysis, reimbursement scenario by key countries, and analysis of patient"s digital health adoption.

REPORT SCOPE AND SEGMENTATION

 Segmentation

By Device Type

  
Diagnostic and Monitoring Devices
  
Electrocardiogram (ECG)
  
Remote Cardiac Monitoring
  
Others
  
Therapeutic and Surgical Devices
  
Ventricular Assist Devices (VAD)
  
Cardiac Rhythm Management (CRM) Devices
  
Catheter
  
Stents
  
Heart Valves
  
Others

By Application

  
Coronary Artery Disease (CAD)
  
Cardiac Arrhythmia
  
Heart Failure
  
Others

By End User

  
Hospitals
  
Specialty Clinics
  
Others

By Geography

  
North America (U.S. and Canada)
  
Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)
  
Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)
  
Latin America (Brazil, Mexico, and Rest of Latin America)
  
Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)